X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.onclive.com/view/ibrutinib-plus-chemoimmunotherapy-fails-to-improve-pfs-in-pretreated-follicular-lymphoma-mzl
https://www.onclive.com/view/lurbinectedin-doxorubicin-misses-os-end-point-in-relapsed-sclc-but-shows-superior-safety-vs-soc
https://www.fiercepharma.com/manufacturing/teva-to-produce-children-s-chemo-drug-again-as-shortage-leads-to-backlash
https://www.fiercepharma.com/manufacturing/pfizer-scrambles-to-fill-void-after-teva-stops-making-chemo-drug-often-children
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-launch-of-evomela-melphalan-for-injection-in-china-300899773.html
https://medcitynews.com/2019/01/spectrum-pharmaceuticals-sells-marketed-drugs-to-aurobindo-subsidiary-for-up-to-300m/?rf=1
https://www.businesswire.com/news/home/20181010005787/en/Celltrion-Teva-Announce-FDA-Oncologic-Drugs-Advisory
http://www.pharmatimes.com/news/abbvie,_j_and_js_imbruvica_fails_to_target_in_b-cell_lymphoma_trial_1244036
https://www.biospace.com/article/abbvie-stock-drops-after-disappointing-clinical-trial-update/
http://www.prnewswire.com/news-releases/casi-pharmaceuticals-import-drug-registration-application-for-evomela-accepted-for-review-by-cfda-300372264.html
http://www.fiercepharmaasia.com/press-releases/spectrum-pharmaceuticals-divests-rights-zevalin-ibritumomab-tiuxetan-japan
http://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-first-patient-dosed-in-phase-2-trial-for-enmd-2076-in-fibrolamellar-carcinoma-flc-300171724.html
Market Place
Share 
